Eva Steiness

Q: What Schools Are Affiliated With Eva Steiness

Eva Steiness is affiliated with the following schools: University of Copenhagen, Copenhagen Business School

Eva Steiness's AcademicInfluence.com Rankings

Eva Steiness

Business

#1189

World Rank

#1330

Historical Rank

Accounting

#282

World Rank

#305

Historical Rank

Management

#547

World Rank

#609

Historical Rank

business Degrees

Eva Steiness

Philosophy

#12038

World Rank

#16656

Historical Rank

Logic

#8853

World Rank

#11131

Historical Rank

philosophy Degrees

Download Badge

Business
Philosophy

Eva Steiness's Degrees

Doctorate Medicine University of Copenhagen
Masters Business Administration Copenhagen Business School

Why Is Eva Steiness Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Eva Steiness née Uhl is a Danish physician, former university professor and businessperson who has been active in Scandinavia's pharmaceutical industry since the late 1990s. She is currently CEO of Serodus ASA, a biomedical company based in Oslo which develops drugs for the treatment of diabetes. In 1982, Steiness became the first women to be appointed dean of Copenhagen University's faculty of medicine and in 1985, she became the first women in Denmark to become a full professor in the medical field with her appointment at Aarhus University.

(See a Problem?)

Eva Steiness's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Renal Tubular Secretion of Digoxin (1974) (205)
Cardiac arrhythmias induced by hypokalaemia and potassium loss during maintenance digoxin therapy. (1976) (133)
A comparative study of serum creatine phosphokinase (CPK) activity in rabbits, pigs and humans after intramuscular injection of local damaging drugs. (2009) (85)
Bumetanide, a new potent diuretic. A clinical evaluation in congestive heart failure. (2009) (79)
Propranolol withdrawal and thyroid hormones in patients with essential hypertension (1978) (59)
Reduction of digoxin‐induced inotropism during quinidine administration (1980) (52)
Different interactions of indomethacin and sulindac with thiazides in hypertension. (1982) (50)
Amiloride‐induced changes in digoxin dynamics and kinetics: Abolition of digoxin‐induced inotropism with amiloride (1981) (46)
Correlation between changes in systolic time intervals and left ventricular end-diastolic diameter after preload reduction. Non-invasive monitoring of pharmacological intervention. (1980) (45)
Tubular sites of furosemide natriuresis in volume-replaced and volume-depleted conscious rats. (1986) (42)
Plasma digoxin after parenteral administration Local reaction after intramuscular injection (1974) (41)
The loss of creatine phosphokinase (CK) from intramuscular injection sites in rabbits. A predictive tool for local toxicity. (2009) (37)
Interactions between digoxin and potassium‐sparing diuretics (1983) (36)
Flow dependence of propranolol elimination in perfused rat liver. (1984) (34)
Pharmacokinetics of oral idarubicin in breast cancer patients with reference to antitumor activity and side effects (1989) (27)
Diuretics, digitalis and arrhythmias. (2009) (24)
Bioavailability of digoxin tablets (1973) (20)
Multiple-dose pharmacokinetics of epirubicin at four different dose levels: studies in patients with metastatic breast cancer (2004) (20)
Effects of propranolol and pindolol on plasma lignocaine clearance in man. (1982) (18)
Dose dependence of proximal and distal tubular effects of furosemide in conscious rats. (1987) (18)
Negative potassium balance during beta‐blocker treatment of hypertension (1982) (17)
DC-conversion of atrial fibrillation after mitral valve operation. An analysis of the long-term results. (1979) (17)
Dose dependency of furosemide-induced sodium excretion. (1989) (16)
DIGOXIN TOXICITY COMPARED WITH MYOCARDIAL DIGOXIN AND POTASSIUM CONCENTRATION (1978) (15)
MYOCARDIAL DIGOXIN UPTAKE: DISSOCIATION BETWEEN DIGITALIS‐INDUCED INOTROPISM AND MYOCARDIAL LOSS OF POTASSIUM (1976) (15)
Renal digoxin clearance: Dependence on plasma digoxin and diuresis (2004) (13)
Diuretic action of bumetanide in congestive heart failure. (1975) (13)
Reduced myocardial blood flow in acute and chronic digitalization. (2009) (13)
Can bismuth decrease the kidney toxic effect of cis-platinum? (1989) (13)
Effects of long-term coenzyme Q10 and captopril treatment on survival and functional capacity in rats with experimentally induced heart infarction. (1990) (13)
Time course of functional deterioration after coronary artery ligation in rats. (1989) (11)
Influence of atenolol and nifedipine on digoxin-induced inotropism in humans. (1984) (10)
TIME COURSE OF OUABAIN UPTAKE IN ISOLATED MYOCARDIAL CELLS: DEPENDENCE ON EXTRACELLULAR POTASSIUM AND CALCIUM CONCENTRATION (1981) (9)
What pharma wants. (2007) (8)
Aprotinin does not add protective effect to cold cardioplegia during coronary artery bypass surgery. (1986) (8)
Thiazide‐induced potassium loss not prevented by beta blockade (1984) (8)
Digoxin concentration in choroid plexus, brain, and myocardium in old age (1978) (8)
Evaluation of increased serum creatine kinase as an indicator of irreversible myocardial damage in dogs. (1987) (8)
Renal Excretion of Digoxin in Swine and Goats (1975) (7)
The electrocardiogram in males with the 47,XYY karyotype. (1970) (6)
Renal handling of iodamide and diatrizoate. Evidence of active tubular secretion of iodamide (1975) (6)
Direct thin-layer densitometric determination of pharmacological concentrations of furosemide in plasma and urine. (1979) (6)
Determination of indomethacin in plasma and urine by direct quantitative thin-layer chromatography. (1979) (6)
The loss of creatine phosphokinase (CK) from intramuscular injection sites in rabbits. A predictive tool for local toxicity [proceedings]. (1979) (6)
Functional pharmacological characterization of SER100 in cardiovascular health and disease (2016) (6)
MYOCARDIAL UPTAKE OF DIGOXIN IN CHRONICALLY DIGITALIZED DOGS (1976) (6)
Furosemide kinetics and dynamics in rats and humans. (1991) (6)
Serum Diazepam and Serum Creatine Kinase after Intra‐muscular Injection of Diazepam in Two Different Vehicles (1978) (5)
The IL-1β Receptor Antagonist SER140 Postpones the Onset of Diabetes in Female Nonobese Diabetic Mice (2016) (5)
The pathogenesis of propranolol-withdrawal syndrome in essential hypertension. (1979) (5)
Similar changes in cardiac morphology and DNA synthesis induced by doxorubicin and 4′-epi-doxorubicin (2004) (4)
Systolic time intervals during spironolactone treatment of digitalized and non-digitalized patients with ischaemic heart disease (2004) (4)
Myocardial protection in coronary artery bypass surgery. A study comparing cold cardioplegia and intermittent aortic cross clamping. (1982) (4)
Effect of probenecid on excretion and natriuretic action of furosemide (1980) (3)
Mammary excretion of digoxin in goats. (2009) (3)
Acute and long-term salt depletion and beta-blockade: plasma renin activity response and its relation to blood pressure reduction in long-term treatment. (1978) (2)
TEMPORAL RELATIONSHIP BETWEEN CARDIAC PERFORMANCE AND MYOCARDIAL UPTAKE OF DL‐PROPRANOLOL IN MAN (1979) (2)
Isolation of cardiac ventricular myocytes from newborn rats by use of fractional elutriation centrifugation. (1989) (2)
Bumetanide-induced natriuresis and antinatriuresis in the proximal and distal parts of the human nephron. Investigations in acute and chronic bumetanide treatment. (1990) (2)
Plasma renin activity and blood pressure during long term treatment with propranolol and diuretic. (2009) (2)
Direct thin-layer chromatography--fluorimetric quantification of pharmacological plasma concentrations of an antiarrhythmic steroid (Org-6001). (1979) (2)
Positive inotropic drugs--digitalis. (2009) (2)
[Bumetanide, a new diuretic. A clinical assessment of the diuretic effect in patients with chronic congestive heart failure]. (1973) (2)
RENAL TUBULAR SECRETION OF DIGOXIN Table 2 Urine Flow and Digoxin Clearance (2)
Atrial content and plasma levels of atrial natriuretic peptides in rats with chronic renal failure. (1988) (2)
Incidence of electrolyte disturbances on the effect of digitalis. (1973) (2)
Felodipine versus Hydrochlorothiazide as an Addition to a β-Blocker in the Treatment of Hypertension (2012) (2)
Acute and Long-Term Salt Depletion and β-blockade: Plasma Renin Activity Response and its Relation to Blood Pressure Reduction in Long-Term Treatment (2009) (1)
[Digoxin-quinidine interactions]. (1981) (1)
[Bumetanide. A comparison between the diuretic effect of bumetanide and furosemide in patients with chronic congestive heart failure]. (1973) (1)
Correlation between changes insystolic timeintervals andleft ventricular end-diastolic diameter after preload (1980) (1)
[Treatment with diuretics. Which preparation is to be chosen?]. (1984) (1)
[Day-to-day variations in plasma digoxin]. (1974) (1)
[Forms of digoxin administration]. (1974) (1)
The efficacy and tolerability of long-term felodipine treatment in hypertension (1990) (1)
[Levels of digoxin in patients receiving oral maintenance therapy]. (1972) (0)
Serum Diazepam and Serum Creatine Kinase after Intra‐muscular Injection of Diazepam in Two Different Vehicles (1978) (0)
[Drug dosage, a question of both the patient's and physician's acceptance of treatment]. (1977) (0)
Reply (1982) (0)
[Local necrosis following intramuscular injection]. (1976) (0)
[Inhalation anesthesia with ultrasonic nebulized lidocaine for fiberoptic bronchoscopy]. (1981) (0)
SERUM POTASSIUM AND THIAZIDE/BETA-BLOCKER COMBINATIONS (1982) (0)
[Value of serum digoxin determination]. (1979) (0)
[Intramuscular injection]. (1976) (0)
[Influence of antipsychotic drugs on the social rehabilitation of schizophrenics]. (1971) (0)
Glp-1 and methods for the treatment of diabetes. (2003) (0)
Beta 2-mediated changes in central haemodynamics, coronary circulation and myocardial metabolism in canine. (1988) (0)
Atrial Natriuretic Peptides (ANP) in Rats with Chronic Renal Failure (1987) (0)
Influence ofatenolol andnifedipine ondigoxin-induced inotropism inhumans (1984) (0)
Doxorubicin binds in a cooperative manner to myocardial cells (1986) (0)
[Research environment and research leadership]. (2001) (0)
[Digoxin tablets]. (1974) (0)
[Methods of determination of serum digoxin and their clinical use]. (1972) (0)
Dose Dependence of Inhibition of Proximal Tubular Sodium Reabsorption by Furosemide in Conscious Rats (1987) (0)

This paper list is powered by the following services:

Other Resources About Eva Steiness

en.wikipedia.org

What Schools Are Affiliated With Eva Steiness?

Eva Steiness is affiliated with the following schools:

Eva Steiness's Academic­Influence.com Rankings

Eva Steiness's Degrees

Why Is Eva Steiness Influential?

Eva Steiness's Published Works

Published Works

Other Resources About Eva Steiness

What Schools Are Affiliated With Eva Steiness?

Eva Steiness's AcademicInfluence.com Rankings